ESC Atlas in Interventional Cardiology in collaboration with EAPCI
The ESC Atlas in Interventional Cardiology is a joint initiative between the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the European Society of Cardiology (ESC). It provides an independent, systematic mapping of interventional cardiology practices across ESC member countries and complements the broader ESC Atlas of Cardiology with detailed subspecialty data.
Interventional Cardiology variables
Click on the category to see a list of all variables within that category
No results found.
-
Cardiological specialists
- Intervention for chronic pulmonary hypertension (per million people)
- Interventional cardiologists (per million people)
- Interventional cardiologists performing transcatheter valvular heart disease interventions (per million people)
- Interventional cardiology operators in training (from your own country) (per million people)
- Total interventional cardiologists (females) (% of interventional cardiologists, total)
- Diagnostic coronary angiography
-
Interventional cardiology infrastructure
- Hospital with cath labs (per million people)
- Hospitals performing TAVI without on-site cardiac surgery (per million people)
- Hospitals with cath labs and on-site cardiac surgery (per million people)
- Hospitals with cath labs on 24 hours/7 days service (per million people)
- Hospitals with cath labs performing TAVI (per million people)
- Hospitals with cath labs performing structural heart disease interventions in the adult (per million people)
- Public hospitals with cardiac cath labs (per million people)
- Total cath labs (per million people)
- Total number of hybrid catheterisation rooms (per million people)
-
Interventional cardiology procedures
- Acute ischemic stroke interventions (per million people)
- Adjunctive intracoronary imaging techniques (per million people)
- Adjunctive intracoronary physiology measurements (per million people)
- Alcohol septum ablations (per million people)
- Aortic balloon valvuloplasties (per million people)
- Atrial septum closures (per million people)
- Coronary bio-resorbable vascular scaffolds (per million people)
- Coronary drug-eluting stents (per million people)
- Coronary stents (per million people)
- Left atrial appendage occlusions (per million people)
- Mitral balloon valvuloplasties (per million people)
- Non-femoral transcatheter aortic valve implantations (per million people)
- Percent of percutaneous coronary interventions (PCI) performed by trans-radial access
- Percutaneous coronary interventions (PCI) (per million people)
- Percutaneous coronary interventions (PCI) for in-stent restenosis (per million people)
- Percutaneous coronary interventions (PCI) in coronary artery with chronic total occlusions (CTO) (per million people)
- Percutaneous coronary interventions (PCI) in unprotected left main (LM) coronary artery (per million people)
- Percutaneous coronary interventions (PCI) performed with adjunctive intracoronary imaging techniques (per million people)
- Percutaneous coronary interventions (PCI) performed with adjunctive intracoronary physiology measurements (per million people)
- Percutaneous coronary interventions (PCI) with bio-resorbable vascular scaffolds (per million people)
- Percutaneous coronary interventions (PCI) with coronary stents (per million people)
- Percutaneous coronary interventions (PCI) with drug-eluting balloons (per million people)
- Percutaneous coronary interventions (PCI) with drug-eluting coronary stents (per million people)
- Percutaneous coronary interventions (PCI) with intravascular lithotripsy (IVL) (per million people)
- Percutaneous coronary interventions (PCI) with rotational or orbital atherectomy (per million people)
- Percutaneous coronary interventions (PCI) without stent (per million people)
- Percutaneous mitral valve interventions (per million people)
- Peri-valvular leaks closures (per million people)
- Primary percutaneous coronary intervention (pPCI) (per million people)
- Procedures with cerebral embolic protection devices (per million people)
- TAVI for pure aortic regurgitation (per million people)
- TAVI performed in native aortic valve (excluding valve in valve) (per million people)
- Transapical transcatheter aortic valve implantations (per million people)
- Transcatheter aortic valve-in-valve implantations in previous TAVIs (per million people)
- Transcatheter aortic valve-in-valve implantations in surgical valve (per million people)
- Transcatheter interventions for congenital heart disease in adults (per million people)
- Transcatheter mitral valve in valve implantation with TAVI device (per million people)
- Transcatheter native mitral valve repairs (per million people)
- Transcatheter native mitral valve replacement (per million people)
- Transcatheter tricuspid valve repairs (per million people)
- Transcatheter tricuspid valve replacement (per million people)
- Transfemoral transcatheter aortic valve implantations (per million people)
- Transvascular transcatheter aortic valve implantations (per million people)
- Use of hemodynamic support devices (per million people)
- Valve-in-valve percutaneous implantations (per million people)
- Ventricular septum closures (per million people)
